Point of Care Molecular Diagnostics�-Global Market Status and Trend Report 2013-2023 | Mart Research
市场研究趋势,行业分析报告沃尔玛研究

Point of Care Molecular Diagnostics�-Global Market Status and Trend Report 2013-2023

  • 概要
  • 目录
  • 表和图
Report Summary Point of Care Molecular Diagnostics�-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Point of Care Molecular Diagnostics� industry, standing on the readers� perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include: Worldwide and Regional Market Size of Point of Care Molecular Diagnostics� 2013-2017, and development forecast 2018-2023 Main manufacturers/suppliers of Point of Care Molecular Diagnostics� worldwide, with company and product introduction, position in the Point of Care Molecular Diagnostics� market Market status and development trend of Point of Care Molecular Diagnostics� by types and applications Cost and profit status of Point of Care Molecular Diagnostics�, and marketing status Market growth drivers and challenges The report segments the global Point of Care Molecular Diagnostics� market as: Global Point of Care Molecular Diagnostics� Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023): North America Europe China Japan Rest APAC Latin America Global Point of Care Molecular Diagnostics� Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023): Assays and Kits Instruments or Analyzers Services and Software Global Point of Care Molecular Diagnostics� Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis) Respiratory Diseases Sexually Transmitted Diseases Hospital-acquired Infection Oncology Hepatitis Others Global Point of Care Molecular Diagnostics� Market: Manufacturers Segment Analysis (Company and Product introduction, Point of Care Molecular Diagnostics� Sales Volume, Revenue, Price and Gross Margin): Myriad Genetics Cepheid Illumina Inc. Abbott Agilent Technologies Inc. Hoffmann-La Roche Ltd. GenePOC Inc. QIAGEN Hologic Inc. Genomic Health Beckman Coulter Inc Siemens Healthcare GmbH DxNA LLC. Abaxis, Bayer AG, Johnson & Johnson Services Inc. Biocartis Binx Health Inc. Grifols S.A. Medtronic Spartan Bioscience Inc. Quidel Corporation bioM�rieux SA Sysmex Corporation BD OraSure Technologies Inc. Bio-Rad Laboratories Inc. Meridian Bioscience Inc. Danaher In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
目录Chapter 1 Overview of Point of Care Molecular Diagnostics� 1.1 Definition of Point of Care Molecular Diagnostics� in This Report 1.2 Commercial Types of Point of Care Molecular Diagnostics� 1.2.1 Assays and Kits 1.2.2 Instruments or Analyzers 1.2.3 Services and Software 1.3 Downstream Application of Point of Care Molecular Diagnostics� 1.3.1 Respiratory Diseases 1.3.2 Sexually Transmitted Diseases 1.3.3 Hospital-acquired Infection 1.3.4 Oncology 1.3.5 Hepatitis 1.3.6 Others 1.4 Development History of Point of Care Molecular Diagnostics� 1.5 Market Status and Trend of Point of Care Molecular Diagnostics� 2013-2023 1.5.1 Global Point of Care Molecular Diagnostics� Market Status and Trend 2013-2023 1.5.2 Regional Point of Care Molecular Diagnostics� Market Status and Trend 2013-2023 Chapter 2 Global Market Status and Forecast by Regions 2.1 Market Development of Point of Care Molecular Diagnostics� 2013-2017 2.2 Production Market of Point of Care Molecular Diagnostics� by Regions 2.2.1 Production Volume of Point of Care Molecular Diagnostics� by Regions 2.2.2 Production Value of Point of Care Molecular Diagnostics� by Regions 2.3 Demand Market of Point of Care Molecular Diagnostics� by Regions 2.4 Production and Demand Status of Point of Care Molecular Diagnostics� by Regions 2.4.1 Production and Demand Status of Point of Care Molecular Diagnostics� by Regions 2013-2017 2.4.2 Import and Export Status of Point of Care Molecular Diagnostics� by Regions 2013-2017 Chapter 3 Global Market Status and Forecast by Types 3.1 Production Volume of Point of Care Molecular Diagnostics� by Types 3.2 Production Value of Point of Care Molecular Diagnostics� by Types 3.3 Market Forecast of Point of Care Molecular Diagnostics� by Types Chapter 4 Global Market Status and Forecast by Downstream Industry 4.1 Demand Volume of Point of Care Molecular Diagnostics� by Downstream Industry 4.2 Market Forecast of Point of Care Molecular Diagnostics� by Downstream Industry Chapter 5 Market Driving Factor Analysis of Point of Care Molecular Diagnostics� 5.1 Global Economy Situation and Trend Overview 5.2 Point of Care Molecular Diagnostics� Downstream Industry Situation and Trend Overview Chapter 6 Point of Care Molecular Diagnostics� Market Competition Status by Major Manufacturers 6.1 Production Volume of Point of Care Molecular Diagnostics� by Major Manufacturers 6.2 Production Value of Point of Care Molecular Diagnostics� by Major Manufacturers 6.3 Basic Information of Point of Care Molecular Diagnostics� by Major Manufacturers 6.3.1 Headquarters Location and Established Time of Point of Care Molecular Diagnostics� Major Manufacturer 6.3.2 Employees and Revenue Level of Point of Care Molecular Diagnostics� Major Manufacturer 6.4 Market Competition News and Trend 6.4.1 Merger, Consolidation or Acquisition News 6.4.2 Investment or Disinvestment News 6.4.3 New Product Development and Launch Chapter 7 Point of Care Molecular Diagnostics� Major Manufacturers Introduction and Market Data 7.1 Myriad Genetics 7.1.1 Company profile 7.1.2 Representative Point of Care Molecular Diagnostics� Product 7.1.3 Point of Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of Myriad Genetics 7.2 Cepheid 7.2.1 Company profile 7.2.2 Representative Point of Care Molecular Diagnostics� Product 7.2.3 Point of Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of Cepheid 7.3 Illumina Inc. 7.3.1 Company profile 7.3.2 Representative Point of Care Molecular Diagnostics� Product 7.3.3 Point of Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of Illumina Inc. 7.4 Abbott 7.4.1 Company profile 7.4.2 Representative Point of Care Molecular Diagnostics� Product 7.4.3 Point of Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of Abbott 7.5 Agilent Technologies Inc. 7.5.1 Company profile 7.5.2 Representative Point of Care Molecular Diagnostics� Product 7.5.3 Point of Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of Agilent Technologies Inc. 7.6 Hoffmann-La Roche Ltd. 7.6.1 Company profile 7.6.2 Representative Point of Care Molecular Diagnostics� Product 7.6.3 Point of Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of Hoffmann-La Roche Ltd. 7.7 GenePOC Inc. 7.7.1 Company profile 7.7.2 Representative Point of Care Molecular Diagnostics� Product 7.7.3 Point of Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of GenePOC Inc. 7.8 QIAGEN 7.8.1 Company profile 7.8.2 Representative Point of Care Molecular Diagnostics� Product 7.8.3 Point of Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of QIAGEN 7.9 Hologic Inc. 7.9.1 Company profile 7.9.2 Representative Point of Care Molecular Diagnostics� Product 7.9.3 Point of Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of Hologic Inc. 7.10 Genomic Health 7.10.1 Company profile 7.10.2 Representative Point of Care Molecular Diagnostics� Product 7.10.3 Point of Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of Genomic Health 7.11 Beckman Coulter Inc 7.11.1 Company profile 7.11.2 Representative Point of Care Molecular Diagnostics� Product 7.11.3 Point of Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of Beckman Coulter Inc 7.12 Siemens Healthcare GmbH 7.12.1 Company profile 7.12.2 Representative Point of Care Molecular Diagnostics� Product 7.12.3 Point of Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of Siemens Healthcare GmbH 7.13 DxNA LLC. 7.13.1 Company profile 7.13.2 Representative Point of Care Molecular Diagnostics� Product 7.13.3 Point of Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of DxNA LLC. 7.14 Abaxis, Bayer AG, 7.14.1 Company profile 7.14.2 Representative Point of Care Molecular Diagnostics� Product 7.14.3 Point of Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of Abaxis, Bayer AG, 7.15 Johnson & Johnson Services Inc. 7.15.1 Company profile 7.15.2 Representative Point of Care Molecular Diagnostics� Product 7.15.3 Point of Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of Johnson & Johnson Services Inc. 7.16 Biocartis 7.17 Binx Health Inc. 7.18 Grifols S.A. 7.19 Medtronic 7.20 Spartan Bioscience Inc. 7.21 Quidel Corporation 7.22 bioM�rieux SA 7.23 Sysmex Corporation 7.24 BD 7.25 OraSure Technologies Inc. 7.26 Bio-Rad Laboratories Inc. 7.27 Meridian Bioscience Inc. 7.28 Danaher Chapter 8 Upstream and Downstream Market Analysis of Point of Care Molecular Diagnostics� 8.1 Industry Chain of Point of Care Molecular Diagnostics� 8.2 Upstream Market and Representative Companies Analysis 8.3 Downstream Market and Representative Companies Analysis Chapter 9 Cost and Gross Margin Analysis of Point of Care Molecular Diagnostics� 9.1 Cost Structure Analysis of Point of Care Molecular Diagnostics� 9.2 Raw Materials Cost Analysis of Point of Care Molecular Diagnostics� 9.3 Labor Cost Analysis of Point of Care Molecular Diagnostics� 9.4 Manufacturing Expenses Analysis of Point of Care Molecular Diagnostics� Chapter 10 Marketing Status Analysis of Point of Care Molecular Diagnostics� 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List Chapter 11 Report Conclusion Chapter 12 Research Methodology and Reference 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Reference
List of Tables Table Advantage and Disadvantage of Assays and Kits Table Advantage and Disadvantage of Instruments or Analyzers Table Advantage and Disadvantage of Services and Software Table Production Volume of Point of Care Molecular Diagnostics� by Regions 2013-2017 Table Production Value of Point of Care Molecular Diagnostics� by Regions 2013-2017 Table Demand Volume of Point of Care Molecular Diagnostics� by Regions 2013-2017 Table Production and Demand Status of Point of Care Molecular Diagnostics� in Region One 2013-2017 Table Production and Demand Status of Point of Care Molecular Diagnostics� in Region Two 2013-2017 Table Production and Demand Status of Point of Care Molecular Diagnostics� in Region Three 2013-2017 Table Production and Demand Status of Point of Care Molecular Diagnostics� in Region Four 2013-2017 Table Import Volume of Point of Care Molecular Diagnostics� by Regions 2013-2017 Table Export Volume of Point of Care Molecular Diagnostics� by Regions 2013-2017 Table Production Volume of Point of Care Molecular Diagnostics� by Types 2013-2017 Table Production Value of Point of Care Molecular Diagnostics� by Types 2013-2017 Table Production Volume Forecast of Point of Care Molecular Diagnostics� by Types 2018-2023 Table Production Value Forecast of Point of Care Molecular Diagnostics� by Types 2018-2023 Table Demand Volume of Point of Care Molecular Diagnostics� by Downstream Industry 2013-2017 Table Demand Volume Forecast of Point of Care Molecular Diagnostics� by Downstream Industry 2018-2023 Table Production Volume of Point of Care Molecular Diagnostics� by Major Manufacturers 2013-2017 Table Production Value of Point of Care Molecular Diagnostics� by Major Manufacturers 2013-2017 Table Headquarters Location and Established Time of Point of Care Molecular Diagnostics� Major Manufacturer Table Employees and Revenue Level of Point of Care Molecular Diagnostics� Major Manufacturer Table Representative Point of Care Molecular Diagnostics� Product One of Myriad Genetics Table Representative Point of Care Molecular Diagnostics� Product Two of Myriad Genetics Table Point of Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of Myriad Genetics 2013-2017 Table Representative Point of Care Molecular Diagnostics� Product One of Cepheid Table Representative Point of Care Molecular Diagnostics� Product Two of Cepheid Table Point of Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of Cepheid 2013-2017 Table Representative Point of Care Molecular Diagnostics� Product One of Illumina Inc. Table Representative Point of Care Molecular Diagnostics� Product Two of Illumina Inc. Table Point of Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of Illumina Inc. 2013-2017 Table Representative Point of Care Molecular Diagnostics� Product One of Abbott Table Representative Point of Care Molecular Diagnostics� Product Two of Abbott Table Point of Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of Abbott 2013-2017 Table Representative Point of Care Molecular Diagnostics� Product One of Agilent Technologies Inc. Table Representative Point of Care Molecular Diagnostics� Product Two of Agilent Technologies Inc. Table Point of Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of Agilent Technologies Inc. 2013-2017 Table Representative Point of Care Molecular Diagnostics� Product One of Hoffmann-La Roche Ltd. Table Representative Point of Care Molecular Diagnostics� Product Two of Hoffmann-La Roche Ltd. Table Point of Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of Hoffmann-La Roche Ltd. 2013-2017 Table Representative Point of Care Molecular Diagnostics� Product One of GenePOC Inc. Table Representative Point of Care Molecular Diagnostics� Product Two of GenePOC Inc. Table Point of Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of GenePOC Inc. 2013-2017 Table Representative Point of Care Molecular Diagnostics� Product One of QIAGEN Table Representative Point of Care Molecular Diagnostics� Product Two of QIAGEN Table Point of Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of QIAGEN 2013-2017 Table Representative Point of Care Molecular Diagnostics� Product One of Hologic Inc. Table Representative Point of Care Molecular Diagnostics� Product Two of Hologic Inc. Table Point of Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of Hologic Inc. 2013-2017 Table Representative Point of Care Molecular Diagnostics� Product One of Genomic Health Table Representative Point of Care Molecular Diagnostics� Product Two of Genomic Health Table Point of Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of Genomic Health 2013-2017 Table Representative Point of Care Molecular Diagnostics� Product One of Beckman Coulter Inc Table Representative Point of Care Molecular Diagnostics� Product Two of Beckman Coulter Inc Table Point of Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of Beckman Coulter Inc 2013-2017 Table Representative Point of Care Molecular Diagnostics� Product One of Siemens Healthcare GmbH Table Representative Point of Care Molecular Diagnostics� Product Two of Siemens Healthcare GmbH Table Point of Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of Siemens Healthcare GmbH 2013-2017 Table Representative Point of Care Molecular Diagnostics� Product One of DxNA LLC. Table Representative Point of Care Molecular Diagnostics� Product Two of DxNA LLC. Table Point of Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of DxNA LLC. 2013-2017 Table Representative Point of Care Molecular Diagnostics� Product One of Abaxis, Bayer AG, Table Representative Point of Care Molecular Diagnostics� Product Two of Abaxis, Bayer AG, Table Point of Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of Abaxis, Bayer AG, 2013-2017 Table Representative Point of Care Molecular Diagnostics� Product One of Johnson & Johnson Services Inc. Table Representative Point of Care Molecular Diagnostics� Product Two of Johnson & Johnson Services Inc. Table Point of Care Molecular Diagnostics� Sales, Revenue, Price and Gross Margin of Johnson & Johnson Services Inc. 2013-2017
付款方式

请留言 向上箭头